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In the nervous system, several key steps in cellular complexity and development are reg-
ulated by non-coding RNAs (ncRNAs) and the repressor element-1 silencing transcription
factor/neuron-restrictive silencing factor (REST/NRSF). REST recruits gene regulatory com-
plexes to regulatory sequences, among them the repressor element-1/neuron-restrictive
silencer element, and mediates developmental stage-speciﬁc gene expression or repres-
sion, chromatin (re-)organization or silencing for protein-coding genes as well as for several
ncRNAs likemicroRNAs, short interferingRNAs or long ncRNAs.NcRNAs are far frombeing
just transcriptional noise and are involved in chromatin accessibility, transcription and post-
transcriptional processing, trafﬁcking, or RNA editing. REST and its cofactor CoREST are
both highly regulated through various ncRNAs. The importance of the correct regulation
within the ncRNA network, the ncRNAome, is demonstrated when it comes to a deregula-
tion of REST and/or ncRNAs associated with molecular pathophysiology underlying diverse
disorders including neurodegenerative diseases or brain tumors.
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INTRODUCTION
Both experimental and computational evidence suggest that many
of the newly discovered non-coding transcripts and process-
ing products, such as the non-coding (ncRNA) small interfering
(siRNA)ormicroRNAs (miRNA),are functional. Likely,weunder-
estimate the complexity of the regulatory circuitry by assuming a
hierarchical structure of well-separated layers in transcriptional
regulation. At least a large fraction of the non-coding transcripts
themselves are functional and are far from being just transcrip-
tional noise – begging the question “What’s regulated in gene
regulation?”. Many of these transcripts show a differential expres-
sion in differentiation and disease; there is also sequence conser-
vation and many of the highly conserved elements give rise to
ncRNAs of heretofore-unknown function. It is of high impor-
tance to understand the fundamental principles in neuroscience,
viz. how cellular complexity, diversity, and development are regu-
lated. Such understanding in both healthy and diseased conditions
will pave the way to target various diseases and to develop novel
drugs and therapeutics. Further, genomic and epigenomic studies
provide insights into the complex mechanisms that underlie the
aforementioned processes, including the important roles of ncR-
NAs and the repressor element-1 silencing transcription factor/
neuron-restrictive silencing factor (REST/NRSF). Looking at the
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complexity of the genome, the whole genome may be transcribed
with each nucleotide potentially serving as a multifunctional unit
within multiple interconnected genomic layers or elements (Bir-
ney et al., 2007). Individual cell types are characterized by their
unique repertoire of protein- and non-coding transcripts and a
cell’s identity and function is determinedby a speciﬁc series of tem-
poral and spatial extracellular cues, combinatorial transcription
factor codes, epigenetic regulatory networks, and complex chro-
matin dynamics. In this context, REST and its cofactor CoREST
play important roles as they bind to genomic regulatory sequences,
including the repressor element-1/neuron-restrictive silencer ele-
ment (RE1/NRSE). REST and CoRESTmodulate a huge variety of
protein-coding (Johnson et al., 2007; Otto et al., 2007) and non-
coding genes (Wu and Xie, 2006; Johnson et al., 2009), regulate
gene expression or repression as well as long-term gene silencing
(Zheng et al., 2009). Within the network regulated by REST and
CoREST, neural genes are connecting points and this network is
highly integrated with the ncRNAome that orchestrates aspects
as diverse as lineage restriction, stem cell maintenance, differen-
tiation, fate determination, or homeostasis (Mehler, 2008). Given
the involvement in these key regulatory pathways, it is not sur-
prising that the perturbation of REST and CoREST activity or the
related ncRNAs are implicated in the molecular pathophysiology
that underlies various diseases. Among these diseases are tumors
likemedullo-, glio-, or neuroblastoma (Coulson, 2005; Blom et al.,
2006;Westbrook et al., 2008), in addition to ischemia (Formisano
et al., 2007), epilepsy (Garriga-Canut et al., 2006; Bassuk et al.,
2008), or neurodegenerative diseases (Zuccato et al., 2007; Benn
et al., 2008; Packer et al., 2008).
REST AND CoREST IN NEURAL NETWORKS
The zinc ﬁnger protein REST binds to genomic sequences that
include canonical RE1 sequences. REST acts as a modulator for
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the assembly of diverse transcription factors. Initially thought to
repress only neuronal genes in non-neuronal cells (Schoenherr
and Anderson, 1995; Ballas et al., 2001), REST is now seen as a
key regulator in multifaceted pathways in various cell types and
as a modulator of the cellular epigenome. In addition to CoR-
EST, REST also recruits mSin3 (Grimes et al., 2000), a scaffold
for histone deacetylases (Hdac-1, -2, -4, and -5). When associ-
ated with REST, CoREST binds to Hdac-1 and -2, histone H3K4
lysine demethylase, LSD1, histone H3K9 methyltransferases, G9a
and Suv39h1, methyl-CpG binding protein 2 (Mecp2), and to a
component of the SWI/SNF chromatin remodeling complex, Brg1
(Andres et al., 1999). REST also associates with a wide number
of epigenetic and regulatory cofactors that include DNA methyl-
transferases (DNMTs), chromatin remodeling enzymes, the RNA
polymerase II transcriptional Mediator subunits, Med-19 and -26
(Ding et al., 2009), the NADH-binding factor, CtBP (Garriga-
Canut et al., 2006; Guardavaccaro et al., 2008), the transcription
factor Sp3 (Kim et al., 2006), or the small C-terminal domain
phosphatase, Scp1 (Visvanathan et al., 2007) (Figure 1). There-
fore, REST acts as a platform for genomic integrity, stability, and
regulation and speciﬁes context-dependent gene repression or
activation. The complexity further increases when looking at the
various parameters that regulate the afﬁnity of the REST complex
through several parameters that include its afﬁnity for binding to
different RE1 and non-RE1 sites, alternative spliced variants of
REST (Shimojo et al., 1999; Lee et al., 2000a), or the modulation
via ncRNAs (Kuwabara et al., 2004; Visvanathan et al., 2007;
Packer et al., 2008).
The locus for REST contains several regulatory elements that
are targeted by transcriptional networks including Nanog and
Oct4 (Singh et al., 2008) or by factors like Wnt and retinoic acid
(Nishihara et al., 2003). The shufﬂing of REST from the nucleus to
the cytoplasm is controlled by huntingtin (Htt) and is controlled
by a complex of Htt, dynactin p150, and REST (Johnson et al.,
2008). Besides the effects of transcriptional regulation, a role of
REST in post-transcriptional processing has been shown for the
μ-opioid receptor (μOR) gene (Kim et al., 2008).
THE INTERPLAY OF REST AND ncRNAs
Since REST contains an RE1 sequence, it may be that REST reg-
ulates its own expression in a feedback loop. In this regard, it is
interesting that small double-stranded ncRNAs encoding the RE1
sequence (dsNRSEs) were found to interact with the REST com-
plex to promote the expressionof RE1-associated genes (Kuwabara
et al., 2005). This fact demonstrates the close link of REST function
and ncRNA expression and is particularly relevant for the deter-
mination of cell fates in the nervous system. Initially, REST was
found to modulate genes for neuronal differentiation, homeosta-
sis and plasticity, including cytokines, neurotransmitter receptors,
ion channels, cell adhesion molecules, growth factors, and fac-
tors for axonal guidance or vesicle proteins at synapses (Chen
et al., 1998). A similar role has been demonstrated for miRNAs
and ncRNA networks in neuronal differentiation and plasticity
(Ooi andWood, 2008).
Genome-wide mapping, expression and binding proﬁles for
REST have been examined in various studies. REST targets both
FIGURE 1 | Schematic diagram illustrating the major components of
ncRNA–REST/NRSF interactions in neural networks. A yet to identiﬁed
mechanism initiates the binding of BRG1 to REST/NRSF, resulting in the
exposure of the RE1/NRSE motif and the subsequent occupation of it by
REST/NRSF. The exact sequential order is unknown.With the assistance of
Sin3 and CoREST, the RE1-bound REST/NRSF complexes recruit histone
deacetylases (HDAC1/2) and CpG methylDNA binding protein (MeCP2), to
promote histone deacetylations, histone methylases (G9a), and histone
demethylases (LSD1). REST/NRSF can recruit additional histone methylases
and demethylases to target lysine residues of histones; arrows link cofactors
to their chromatin remodeling and modifying activities. Inhibition of these
histone modifying components results in an attenuation of REST/NRSF
recruitment, a decrease in H3K9me2, an increase in H3K9/K14 and H4
acetylation, an increase in H3K4me3 and a decrease in binding of MeCP2 to
methylated DNA. REST/NRSF-mediated regulation of neuronal gene
expression relies on the dissociation of the REST/NRSF repressor complex
from the RE1/NRSE site. In addition to the REST/NRSF complex at the
RE1/NRSE site, CoREST and MeCP2 complexes bind to genes on adjacent
methylated CpGs in their promoters throughout neuronal differentiation. In
neural progenitors, REST/NRSF is expressed and inhibits miR-124a
expression, allowing the persistence of non-neuronal transcripts. Upon
differentiation of the neuronal progenitors into neurons, REST/NRSF
dissociation from the miR-124a gene loci induces derepression of the gene,
resulting in the selective degradation of non-neuronal gene transcripts. Thus,
REST/NRSF links transcriptional and post-transcriptional events to ﬁne-tune
the balance of phenotype between neuronal and non-neuronal cells,
controlled by miR-124 and further non-coding transcripts (ncRNA) that act in a
network with miR-124. See text for references.
Frontiers in Genetics | Non-Coding RNA February 2011 | Volume 2 | Article 8 | 2
Rossbach ncRNAs and REST
the canonical and non-canonical RE1 sequence that contains
insertions in the canonical sequence of variable lengths (Ooi and
Wood, 2007; Otto et al., 2007). NcRNAs are believed to play
an important role in the regulation of REST binding to such
sequences. Among them are miRNAs that are cell type-speciﬁc
and are only expressed in the brain, viz. miR-9, miR-124, or miR-
128 (Ooi and Wood, 2008) (Figure 1). MiRNAs directly target
the 3′-untranslated region (UTR) of target mRNAs leading to a
sequestration of mRNAs in P-bodies for storage or subsequent
degradation, respectively. P-bodies regulate RNA metabolism,
translational repression and play a critical role in the transport
of RNAs to dendrites regulating synaptic plasticity (Zeitelhofer et
al., 2008). Many functions of the complex ncRNAome are yet to
be uncovered, however, a large number of RE1 sites are present
within close proximity of nervous system enriched miRNA genes
– and the expression of those genes is regulated by REST (Wu and
Xie, 2006).
The important role of critical components of the RNAi medi-
ated gene silencing pathways has been demonstrated for factors
that are associated with RE1, such as Argonaute (Ago1, Ago3,
Ago4, Xpo5) or Dicer (Dicer1) proteins (Nishihara et al., 2003;
Rossbach, 2010). REST itself may be targeted by multiple ncR-
NAs, such as the miRNAs mir-9 or miR-124 (Wu and Xie, 2006;
Packer et al., 2008) and, consequently, theremay be several layers of
regulation connected in neurodevelopment, e.g., double-negative
feedback loops for REST and ncRNAs. There are further classes
of non-coding regulators of REST, like long ncRNAs; 23% of the
REST binding sites lie within a 10-kb region of long ncRNA genes
(Shimojo et al., 1999). For instance, when looking at the DiGe-
orge syndrome, the locus of the DiGeorge syndrome-associated
ncRNA DGCR5 is a breakpoint region, which is characterized
by malformations during neurodevelopment and causes neu-
ropsychiatric diseases. REST binds to a binding site of DGCR5,
leading to transcriptional repression (Johnson et al., 2009). Mam-
malian genomes may encode huge amounts of such long ncRNAs,
many of them are poly-A tailed, highly regulated during devel-
opment, alternately spliced, and enriched in the nervous system.
In the brain and in embryonic stem cells (ESCs), long ncRNAs
exhibit cell type-speciﬁc, spatial, and temporal regulated expres-
sion proﬁles (Dinger et al., 2008a) Besides transcription, post-
transcriptional processing, RNA editing, and trafﬁcking (Mehler,
2008), ncRNAs regulate chromosomal architecture, dynamics and
plasticity by recruiting chromatin activator or repressor com-
plexes to their targets (Mattick et al., 2009). An example is the
ncRNAAir that accumulates at promoter regions where it silences
gene expression by recruiting the H3K9 methyltransferase G9a
(Nagano et al., 2008) (Figure 1).
NETWORK REGULATIONS MEDIATED BY ncRNAs
Non-coding transcripts not only include miRNA, siRNAs, and
long ncRNAs, but also small nucleolar RNAs (snoRNA) and anti-
sense RNAs (asRNAs) – but it is quite likely that further classes
of ncRNAs will emerge. Given the complex regulatory networks,
REST and CoREST may function as dynamic mediators of regu-
lation, thus regulating transcription, chromatin architecture and
responding to epigenetic signals (Gan et al., 2007). REST has
been implicated in cell- and tissue-speciﬁc epigenetics, and is, like
CoREST, crucial in neural stem cells (NSCs) and non-neuronal
cells, but also in ESCs, neuronal and glial progenitor cells, or in
terminally differentiated neurons and glia. During speciﬁc lineage
determination, silencing of genes involved in lineage speciﬁca-
tion and pluripotency takes place. Thus, REST is highly integrated
with the network of transcription inmaintenance of pluripotency,
viz. Oct4, Nanog, or Sox2 (Singh et al., 2008; Jorgensen et al.,
2009a). Studies suggest that REST is involved in ESC pluripo-
tency by targeting miRNAs like miR-21 (Singh et al., 2008); other
studies, however, ﬁnd conﬂicting results and show no signiﬁcant
impact of REST on the maintenance of pluripotency (Buckley
et al., 2009; Jorgensen et al., 2009a). Besides its potential role in
pluripotency, REST is implicated in the silencing of RE1 asso-
ciated genes in ESCs, among them genes important for neuronal
terminal differentiation or function. Examples include, but are not
limited to, Syt4, Syp, Stmn3, or Celsr3. However, Mash1 or Math1
are not on this list, suggesting that REST does not repress the
potential for neural lineage commitment but silences genes impor-
tant for neuronal subtype speciﬁcation in ESCs (Jorgensen et al.,
2009b). The role of REST in neurogenesis has been demonstrated
through the interaction of REST and ncRNAs encoding the RE1
sequence (dsNRSEs); here, REST acts as an activator and induces
neuronal differentiation (Kuwabara et al., 2005). REST-deﬁcient
NSCs show defective behavior in regard to migration and survival
(Sun et al., 2008).
Repressor element-1 silencing transcription factor is down-
regulated during NSC differentiation (Westbrook et al., 2008)
and regulates the nervous system speciﬁc miRNA miR-124 that
silences several non-neuronal genes; in non-neuronal cells, REST
silences miR-124 (Wu and Xie, 2006). During the maturation of
neurons, however, REST is suppressed and thus miR-124 levels
rise. Such observations implicate that REST plays a critical role
in neurodevelopment and in regional neuronal subtype and glial
lineage speciﬁcation, with CoREST mediating NSC maintenance
and maturational functions (Qureshi and Mehler, 2009).
INCREASING COMPLEXITY IN NEURAL NETWORKS
In healthy and diseased contexts, REST levels vary signiﬁcantly,
and both overexpression and downregulation of REST have been
observed in various disease phenotypes. Thus, REST can act as a
tumor suppressor and oncogene, respectively, depending on the
cellular environment (Westbrook et al., 2005; Weissman, 2008).
With respect to the ncRNAome, several altered levels of ncRNA
expression have been observed in various cancer phenotypes,
among them neuroblastoma or glioblastoma multiforme in the
nervous system (Nicoloso and Calin, 2008; Skog et al., 2008),
and such observations demonstrate how an aberrant expression of
REST and CoREST is involved in pathogenesis of several disorders
like cancer, neurodevelopmental, or neurodegenerative diseases.
When looking at the epigenome, it is becomingmore andmore
evident that REST and its associated factors are critical modula-
tors during development, lineage speciﬁcation or gene regulation
in general and that all these processes depend on epigenetic sig-
nals. Here, another feedback regulation is in place since REST
not only mediates responses to epigenetic signal, but also targets
receptor expression or components of the signaling cascade – with
ncRNAs being important for the execution of these regulatory
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processes. During neurodevelopment, the correct modiﬁcations
of RNAs are crucial, like RNA trafﬁcking, editing, or alternative
splicing. Such processes are regulated in a complex interplay of
REST, ncRNAs, and cofactors like Ptbp1 that is directly targeted by
miR-124. While neuronal differentiation is progressing, miR-124
downregulates Ptbp1, leading to an increase in Ptbp2. Ptbp2 is
the nervous system homolog of Ptbp1, mediates neuron speciﬁc
alternative RNA splicing (Makeyev et al., 2007) and is targeted by
REST and CoREST during neural lineage speciﬁcation.
This complexity further increases when considering the fact
that REST has several isoforms with synergistic or antagonistic
effects for the regulatory network REST is integrated in Coulson et
al. (2000), Lee et al. (2000b), Shimojo et al. (1999). Protein-coding
RNA and ncRNA modiﬁcations, trafﬁcking, functional modiﬁ-
cations, cellular signaling, and epigenetic signal processing seem
to be modulated by REST, CoREST, and ncRNAs (Dinger et al.,
2008b). However, further studies are required to elucidate the full
picture of REST medicated ncRNA networks.
CONCLUDING REMARKS – THE THERAPEUTIC IMPLICATIONS
The emerging concepts of ncRNAs as novel therapeutics and diag-
nostics in neurological diseases bear both great potentials and
challenges. Several mutations, deletions, ampliﬁcations, and alter-
ations have been found in neurological and neurodegenerative
diseases and were shown to alter the expression levels of ncRNA
transcripts, like lncRNAs or miRNAs. A large fraction of highly
conserved regions encodes for sets of ncRNAs whose expression is
altered during disease progression. Besides the molecular and bio-
chemical studies, bioinformatics, and systems biology approaches
becomemore andmore important as tools to identify associations
and correlations between ncRNAs and gene regulatory networks
since ncRNA proﬁles allow the identiﬁcation of various signatures
that are associated with diagnosis, prognosis, and the response
to treatment of neurological, neurodegenerative diseases, or brain
tumors. Detailed ncRNAome proﬁles are a ﬁrst step toward dis-
coveries leading to novel therapeutics since they were shown to
affect brain tumor development or progression and are impli-
cated in various diseases. Speciﬁcally addressing changes in the
ncRNAome in disease contexts with tools that focus on si-, lncR-
NAs, and miRNAs will lead to important ﬁndings with respect
to biomarker discovery and the identiﬁcation of novel therapeutic
targets. The targeting of the ncRNAome is becoming an important
therapeutic and diagnostic strategy, a concept known as theranos-
tics, and is therefore highly relevant for drug development and
personalized medicine. Examples include the restoration of the
expression of a deﬁcient or downregulated ncRNAor, alternatively,
the inhibition of an overexpressed ncRNA to reverse a disease phe-
notype. The silencing of oncogenic and the re-activation of tumor
suppressor miRNAs, for instance, are possible therapeutic para-
digms that are currently being tested in clinical trials. If successful,
such compounds represent new tools for the treatment of cancer
and other diseases. With their unique sequences and secondary
structural elements, ncRNAs comprise potential binding sites for
small molecular drugs acting either as agonists or antagonists,
respectively. Further areas of intervention with small molecules,
aptamers, peptides, or oligonucleotides are (i) the interaction of
ncRNAs with epigenetic effector molecules or (ii) with speciﬁc
RNA degradation pathways. Both therapeutic options can be used
to target aberrant gene expression; however, they require further
validation. Thus, the understanding of the basic processes of gene
regulation may lead toward innovative therapeutic strategies for
personalized treatments of various human diseases.
REFERENCES
Andres, M. E., Burger, C., Peral-Rubio,
M. J., Battaglioli, E., Anderson, M.
E., Grimes, J., Dallman, J., Ballas, N.,
and Mandel, G. (1999). CoREST: a
functional corepressor required for
regulation of neural-speciﬁc gene
expression. Proc. Natl. Acad. Sci.
U.S.A. 96, 9873–9878.
Ballas, N., Battaglioli, E., Atouf, F.,
Andres,M. E.,Chenoweth, J.,Ander-
son, M. E., Burger, C., Moniwa, M.,
Davie, J. R., Bowers, W. J., Federoff,
H. J., Rose, D. W., Rosenfeld, M. G.,
Brehm, P., and Mandel, G. (2001).
Regulation of neuronal traits by a
novel transcriptional complex. Neu-
ron 31, 353–365.
Bassuk, A. G., Wallace, R. H., Buhr,
A., Buller, A. R., Afawi, Z., Shimojo,
M., Miyata, S., Chen, S., Gonzalez-
Alegre, P., Griesbach, H. L., Wu, S.,
Nashelsky, M., Vladar, E. K., Antic,
D., Ferguson, P. J., Cirak, S., Voit,
T., Scott, M. P., Axelrod, J. D., Gur-
nett, C., Daoud, A. S., Kivity, S.,
Neufeld, M. Y., Mazarib, A., Strauss-
berg, R., Walid, S., Korczyn, A. D.,
Slusarski, D. C., Berkovic, S. F., and
El-Shanti, H. I. (2008). A homozy-
gousmutation in human PRICKLE1
causes an autosomal-recessive pro-
gressive myoclonus epilepsy-ataxia
syndrome. Am. J. Hum. Genet. 83,
572–581.
Benn, C. L., Sun, T., Sadri-Vakili, G.,
McFarland, K. N., DiRocco, D. P.,
Yohrling, G. J., Clark, T. W., Bouzou,
B., and Cha, J. H. (2008). Huntingtin
modulates transcription, occupies
gene promoters in vivo, and binds
directly to DNA in a polyglutamine
dependent manner. J. Neurosci. 28,
10720–10733.
Birney, E., Stamatoyannopoulos, J. A.,
Dutta, A., Guigo, R., Gingeras, T.
R., Margulies, E. H., Weng, Z., Sny-
der, M., Dermitzakis, E. T., Thur-
man, R. E., Kuehn, M. S., Tay-
lor, C. M., Neph, S., Koch, C. M.,
Asthana, S., Malhotra, A., Adzhubei,
I., Greenbaum, J. A., Andrews, R.
M., Flicek, P., Boyle, P. J., Cao, H.,
Carter, N. P., Clelland, G. K., Davis,
S., Day, N., Dhami, P., Dillon, S. C.,
Dorschner, M. O., Fiegler, H., Giresi,
P. G., Goldy, J., Hawrylycz, M., Hay-
dock, A., Humbert, R., James, K.
D., Johnson, B. E., Johnson, E. M.,
Frum, T. T., Rosenzweig, E. R., Kar-
nani, N., Lee, K., Lefebvre, G. C.,
Navas, P. A., Neri, F., Parker, S. C.,
Sabo, P. J., Sandstrom, R., Shafer, A.,
Vetrie, D.,Weaver,M.,Wilcox, S., Yu,
M., Collins, F. S., Dekker, J., Lieb,
J. D., Tullius, T. D., Crawford, G.
E., Sunyaev, S., Noble, W. S., Dun-
ham, I., Denoeud, F., Reymond, A.,
Kapranov, P., Rozowsky, J., Zheng,
D., Castelo, R., Frankish, A., Harrow,
J., Ghosh, S., Sandelin, A., Hofacker,
I. L., Baertsch, R., Keefe, D., Dike,
S., Cheng, J., Hirsch, H. A., Sekinger,
E. A., Lagarde, J., Abril, J. F., Sha-
hab, A., Flamm, C., Fried, C., Hack-
ermuller, J., Hertel, J., Lindemeyer,
M., Missal, K., Tanzer, A., Washietl,
S., Korbel, J., Emanuelsson, O., Ped-
ersen, J. S., Holroyd, N., Taylor, R.,
Swarbreck, D., Matthews, N., Dick-
son, M. C., Thomas, D. J.,Weirauch,
M. T., Gilbert, J., Drenkow, J., Bell,
I., Zhao, X., Srinivasan, K. G., Sung,
W. K., Ooi, H. S., Chiu, K. P.,
Foissac, S., Alioto, T., Brent, M.,
Pachter, L., Tress, M. L., Valencia, A.,
Choo, S. W., Choo, C. Y., Ucla, C.,
Manzano, C., Wyss, C., Cheung, E.,
Clark, T. G., Brown, J. B., Ganesh,
M., Patel, S., Tammana, H., Chrast,
J., Henrichsen, C. N., Kai, C., Kawai,
J., Nagalakshmi, U., Wu, J., Lian, Z.,
Lian, J., Newburger, P., Zhang, X.,
Bickel, P., Mattick, J. S., Carninci, P.,
Hayashizaki, Y., Weissman, S., Hub-
bard, T., Myers, R. M., Rogers, J.,
Stadler, P. F., Lowe, T. M., Wei, C.
L., Ruan, Y., Struhl, K., Gerstein, M.,
Antonarakis, S. E., Fu, Y., Green, E.
D., Karaoz, U., Siepel, A., Taylor, J.,
Liefer, L. A., Wetterstrand, K. A.,
Good, P. J., Feingold, E. A., Guyer,
M. S., Cooper, G. M., Asimenos, G.,
Dewey, C. N., Hou, M., Nikolaev, S.,
Montoya-Burgos, J. I., Loytynoja,A.,
Whelan,S.,Pardi,F.,Massingham,T.,
Huang, H., Zhang, N. R., Holmes,
I., Mullikin, J. C., Ureta-Vidal, A.,
Paten, B., Seringhaus, M., Church,
D., Rosenbloom, K., Kent, W. J.,
Stone, E. A., Batzoglou, S.,Goldman,
N., Hardison, R. C., Haussler, D.,
Miller, W., Sidow, A., Trinklein, N.
D., Zhang, Z. D., Barrera, L., Stuart,
R., King,D. C.,Ameur,A., Enroth, S.,
Bieda, M. C., Kim, J., Bhinge, A. A.,
Frontiers in Genetics | Non-Coding RNA February 2011 | Volume 2 | Article 8 | 4
Rossbach ncRNAs and REST
Jiang, N., Liu, J., Yao, F., Vega, V. B.,
Lee, C. W., Ng, P., Yang, A., Moq-
taderi, Z., Zhu, Z., Xu, X., Squazzo,
S., Oberley, M. J., Inman, D., Singer,
M. A., Richmond, T. A., Munn, K.
J., Rada-Iglesias, A., Wallerman, O.,
Komorowski, J., Fowler, J. C., Cout-
tet, P., Bruce, A. W., Dovey, O. M.,
Ellis, P. D., Langford, C. F., Nix,
D. A., Euskirchen, G., Hartman, S.,
Urban, A. E., Kraus, P., Van Cal-
car, S., Heintzman, N., Kim, T. H.,
Wang, K., Qu, C., Hon, G., Luna,
R., Glass, C. K., Rosenfeld, M. G.,
Aldred, S. F., Cooper, S. J., Halees,
A., Lin, J. M., Shulha, H. P., Xu,
M., Haidar, J. N., Yu, Y., Iyer, V. R.,
Green, R. D., Wadelius, C., Farn-
ham, P. J., Ren, B., Harte, R. A., Hin-
richs, A. S., Trumbower, H., Claw-
son, H., Hillman-Jackson, J., Zweig,
A. S., Smith, K., Thakkapallayil, A.,
Barber, G., Kuhn, R. M., Karolchik,
D., Armengol, L., Bird, C. P., de
Bakker, P. I., Kern, A. D., Lopez-
Bigas, N., Martin, J. D., Stranger,
B. E., Woodroffe, A., Davydov, E.,
Dimas,A., Eyras, E.,Hallgrimsdottir,
I. B.,Huppert, J., Zody,M. C.,Abeca-
sis, G. R., Estivill, X., Bouffard,G. G.,
Guan, X., Hansen, N. F., Idol, J. R.,
Maduro, V. V., Maskeri, B., McDow-
ell, J. C., Park, M., Thomas, P. J.,
Young,A.C.,Blakesley,R.W.,Muzny,
D. M., Sodergren, E., Wheeler, D.
A., Worley, K. C., Jiang, H., Wein-
stock, G. M., Gibbs, R. A., Graves, T.,
Fulton, R., Mardis, E. R., Wilson, R.
K., Clamp, M., Cuff, J., Gnerre, S.,
Jaffe, D. B., Chang, J. L., Lindblad-
Toh, K., Lander, E. S., Koriabine, M.,
Nefedov, M., Osoegawa, K., Yoshi-
naga, Y., Zhu, B., and de Jong, P.
J. (2007). Identiﬁcation and analy-
sis of functional elements in 1% of
the human genome by the ENCODE
pilot project. Nature 447, 799–816.
Blom, T., Tynninen, O., Puputti, M.,
Halonen, M., Paetau, A., Haapasalo,
H.,Tanner,M.,andNupponen,N.N.
(2006).Molecular genetic analysis of
the REST/NRSF gene in nervous sys-
tem tumors. Acta Neuropathol. 112,
483–490.
Buckley, N. J., Johnson, R., Sun, Y. M.,
and Stanton, L. W. (2009). Is REST
a regulator of pluripotency? Nature
457, E5–E6.
Chen, Z. F., Paquette, A. J., and Ander-
son, D. J. (1998). NRSF/REST is
required in vivo for repression of
multiple neuronal target genes dur-
ing embryogenesis. Nat. Genet. 20,
136–142.
Coulson, J. M. (2005). Transcriptional
regulation: cancer, neurons and the
REST. Curr. Biol. 15, R665–R668.
Coulson, J. M., Edgson, J. L., Woll, P.
J., and Quinn, J. P. (2000). A splice
variant of the neuron restrictive
silencer factor repressor is expressed
in small cell lung cancer: a poten-
tial role in derepression of neuroen-
docrine genes and a useful clinical
marker. Cancer Res. 60, 1840–1844.
Ding, N., Tomomori-Sato, C., Sato, S.,
Conaway, R. C., Conaway, J. W., and
Boyer, T. G. (2009). MED19 and
MED26 are synergistic functional
targets of the RE1 silencing tran-
scription factor in epigenetic silenc-
ing of neuronal gene expression. J.
Biol. Chem. 284, 2648–2656.
Dinger, M. E., Amaral, P. P., Mercer, T.
R., Pang, K. C., Bruce, S. J., Gar-
diner, B. B., Askarian-Amiri, M. E.,
Ru,K., Solda,G., Simons,C., Sunkin,
S. M., Crowe, M. L., Grimmond, S.
M., Perkins, A. C., and Mattick, J. S.
(2008a). Long noncoding RNAs in
mouse embryonic stem cell pluripo-
tency and differentiation. Genome
Res. 18, 1433–1445.
Dinger,M.E.,Mercer,T. R., andMattick,
J. S. (2008b). RNAs as extracel-
lular signaling molecules. J. Mol.
Endocrinol. 40, 151–159.
Formisano, L., Noh, K. M., Miyawaki,
T., Mashiko, T., Bennett, M. V., and
Zukin, R. S. (2007). Ischemic insults
promote epigenetic reprogramming
of mu opioid receptor expression
in hippocampal neurons. Proc. Natl.
Acad. Sci. U.S.A. 104, 4170–4175.
Gan, Q., Yoshida, T., McDonald, O.
G., and Owens, G. K. (2007). Con-
cise review: epigenetic mechanisms
contribute to pluripotency and cell
lineage determination of embryonic
stem cells. Stem Cells 25, 2–9.
Garriga-Canut, M., Schoenike, B., Qazi,
R., Bergendahl, K., Daley, T. J.,
Pfender, R. M., Morrison, J. F., Ock-
uly, J., Stafstrom, C., Sutula, T.,
and Roopra, A. (2006). 2-Deoxy-
d-glucose reduces epilepsy pro-
gression by NRSF-CtBP-dependent
metabolic regulation of chromatin
structure. Nat. Neurosci. 9, 1382–
1387.
Grimes, J. A., Nielsen, S. J., Battaglioli,
E., Miska, E. A., Speh, J. C., Berry, D.
L.,Atouf, F.,Holdener,B. C.,Mandel,
G., and Kouzarides, T. (2000). The
co-repressor mSin3A is a functional
component of the REST-CoREST
repressor complex. J. Biol. Chem.
275, 9461–9467.
Guardavaccaro, D., Frescas, D., Dor-
rello, N. V., Peschiaroli, A., Mul-
tani, A. S., Cardozo, T., Lasorella, A.,
Iavarone, A., Chang, S., Hernando,
E., and Pagano, M. (2008). Control
of chromosome stability by the beta-
TrCP-REST-Mad2 axis. Nature 452,
365–369.
Johnson, D. S., Mortazavi, A., Myers,
R. M., and Wold, B. (2007).
Genome-wide mapping of in vivo
protein-DNA interactions. Science
316, 1497–1502.
Johnson, R., Teh, C. H., Jia, H., Vanisri,
R. R., Pandey, T., Lu, Z. H., Buckley,
N. J., Stanton, L. W., and Lipovich,
L. (2009). Regulation of neural
macroRNAs by the transcriptional
repressor REST. RNA 15, 85–96.
Johnson, R., Zuccato, C., Belyaev, N.
D., Guest, D. J., Cattaneo, E., and
Buckley, N. J. (2008). A microRNA-
based gene dysregulation pathway in
Huntington’s disease.Neurobiol. Dis.
29, 438–445.
Jorgensen, H. F., Chen, Z. F., Merken-
schlager, M., and Fisher, A. G.
(2009a). Is REST required for ESC
pluripotency? Nature 457, E4–E5
[discussion E7].
Jorgensen, H. F., Terry, A., Beretta, C.,
Pereira, C. F., Leleu, M., Chen, Z. F.,
Kelly, C., Merkenschlager, M., and
Fisher, A. G. (2009b). REST selec-
tively represses a subset of RE1-
containing neuronal genes in mouse
embryonic stem cells. Development
136, 715–721.
Kim, C. S., Choi, H. S., Hwang, C. K.,
Song, K. Y., Lee, B. K., Law, P. Y.,
Wei, L. N., and Loh, H. H. (2006).
Evidence of the neuron-restrictive
silencer factor (NRSF) interaction
with Sp3 and its synergic repression
to the mu opioid receptor (MOR)
gene. Nucleic Acids Res. 34, 6392–
6403.
Kim, C. S., Hwang, C. K., Song, K. Y.,
Choi, H. S., Kim do, K., Law, P. Y.,
Wei, L. N., and Loh, H. H. (2008).
Novel function of neuron-restrictive
silencer factor (NRSF) for posttran-
scriptional regulation. Biochim. Bio-
phys. Acta 1783, 1835–1846.
Kuwabara, T., Hsieh, J., Nakashima, K.,
Taira, K., and Gage, F. H. (2004). A
small modulatory dsRNA speciﬁes
the fate of adult neural stem cells.
Cell 116, 779–793.
Kuwabara, T., Hsieh, J., Nakashima, K.,
Warashina, M., Taira, K., and Gage,
F.H. (2005). TheNRSEsmRNAspec-
iﬁes the fate of adult hippocampal
neural stemcells.NucleicAcids Symp.
Ser. (Oxf.) 87–88.
Lee, J. H., Chai, Y. G., and Hersh, L.
B. (2000a). Expression patterns of
mouse repressor element-1 silenc-
ing transcription factor 4 (REST4)
and its possible function in neu-
roblastoma. J. Mol. Neurosci. 15,
205–214.
Lee, J. H., Shimojo, M., Chai, Y. G.,
and Hersh, L. B. (2000b). Studies
on the interaction of REST4 with
the cholinergic repressor element-
1/neuron restrictive silencer ele-
ment. Brain Res. Mol. Brain Res. 80,
88–98.
Makeyev, E. V., Zhang, J., Carrasco, M.
A., and Maniatis, T. (2007). The
microRNA miR-124 promotes neu-
ronal differentiation by triggering
brain-speciﬁc alternative pre-mRNA
splicing. Mol. Cell 27, 435–448.
Mattick, J. S., Amaral, P. P., Dinger, M.
E., Mercer, T. R., and Mehler, M. F.
(2009).RNAregulationof epigenetic
processes. Bioessays 31, 51–59.
Mehler, M. F. (2008). Epigenetic prin-
ciples and mechanisms underlying
nervous system functions in health
and disease. Prog. Neurobiol. 86,
305–341.
Nagano, T., Mitchell, J. A., Sanz, L. A.,
Pauler, F. M., Ferguson-Smith, A.
C., Feil, R., and Fraser, P. (2008).
The air noncoding RNA epigeneti-
cally silences transcription by target-
ing G9a to chromatin. Science 322,
1717–1720.
Nicoloso, M. S., and Calin, G. A.
(2008). MicroRNA involvement in
brain tumors: from bench to bed-
side. Brain Pathol. 18, 122–129.
Nishihara, S., Tsuda, L., and Ogura, T.
(2003). The canonical Wnt path-
way directly regulates NRSF/REST
expression in chick spinal cord.
Biochem. Biophys. Res. Commun.
311, 55–63.
Ooi, L., and Wood, I. C. (2007). Chro-
matin crosstalk in development and
disease: lessons fromREST.Nat. Rev.
Genet. 8, 544–554.
Ooi, L., and Wood, I. C. (2008). Reg-
ulation of gene expression in the
nervous system. Biochem. J. 414,
327–341.
Otto, S. J., McCorkle, S. R., Hover, J.,
Conaco, C., Han, J. J., Impey, S.,
Yochum, G. S., Dunn, J. J., Good-
man, R. H., and Mandel, G. (2007).
A new binding motif for the tran-
scriptional repressor REST uncov-
ers large gene networks devoted to
neuronal functions. J. Neurosci. 27,
6729–6739.
Packer, A. N., Xing, Y., Harper, S.
Q., Jones, L., and Davidson, B. L.
(2008). The bifunctional microRNA
miR-9/miR-9* regulates REST and
CoREST and is downregulated in
Huntington’s disease. J. Neurosci. 28,
14341–14346.
Qureshi, I. A., andMehler,M. F. (2009).
Regulation of non-coding RNA net-
works in the nervous system –what’s
the REST of the story?Neurosci. Lett.
466, 73–80.
Rossbach,M. (2010). Small non-coding
RNAs as novel therapeutics. Curr.
Mol. Med. 10, 361–368.
Schoenherr, C. J., and Anderson, D. J.
(1995). The neuron-restrictive silen-
cer factor (NRSF): a coordinate rep-
ressor of multiple neuron-speciﬁc
genes. Science 267, 1360–1363.
www.frontiersin.org February 2011 | Volume 2 | Article 8 | 5
Rossbach ncRNAs and REST
Shimojo, M., Paquette, A. J., Ander-
son, D. J., and Hersh, L. B. (1999).
Protein kinase A regulates choliner-
gic gene expression in PC12 cells:
REST4 silences the silencing activ-
ity of neuron-restrictive silencer fac-
tor/REST. Mol. Cell. Biol. 19, 6788–
6795.
Singh, S. K., Kagalwala, M. N., Parker-
Thornburg, J., Adams, H., and
Majumder, S. (2008). REST main-
tains self-renewal and pluripotency
of embryonic stem cells.Nature 453,
223–227.
Skog, J., Wurdinger, T., van Rijn, S.,
Meijer, D. H., Gainche, L., Sena-
Esteves, M., Curry W. T. Jr., Carter,
B. S., Krichevsky, A. M., and Breake-
ﬁeld, X. O. (2008). Glioblastoma
microvesicles transport RNA and
proteins that promote tumor growth
and provide diagnostic biomarkers.
Nat. Cell Biol. 10, 1470–1476.
Sun, Y. M., Cooper, M., Finch, S.,
Lin, H. H., Chen, Z. F., Williams,
B. P., and Buckley, N. J. (2008).
Rest-mediated regulation of extra-
cellular matrix is crucial for neural
development. PLoS ONE 3, e3656.
doi: 10.1371/journal.pone.0003656
Visvanathan, J., Lee, S., Lee, B., Lee, J.W.,
andLee,S.K. (2007). ThemicroRNA
miR-124 antagonizes the anti-neural
REST/SCP1 pathway during embry-
onic CNS development. Genes Dev.
21, 744–749.
Weissman, A. M. (2008). How much
REST is enough? Cancer Cell 13,
381–383.
Westbrook,T. F.,Hu,G.,Ang,X. L.,Mul-
ligan, P., Pavlova, N. N., Liang, A.,
Leng, Y., Maehr, R., Shi, Y., Harper,
J. W., and Elledge, S. J. (2008).
SCFbeta-TRCP controls oncogenic
transformation and neural differen-
tiation through REST degradation.
Nature 452, 370–374.
Westbrook, T. F., Martin, E. S.,
Schlabach, M. R., Leng, Y., Liang,
A. C., Feng, B., Zhao, J. J., Roberts,
T. M., Mandel, G., Hannon, G. J.,
Depinho,R.A.,Chin,L., andElledge,
S. J. (2005). A genetic screen for can-
didate tumor suppressors identiﬁes
REST. Cell 121, 837–848.
Wu, J., and Xie, X. (2006). Comparative
sequence analysis reveals an intricate
network among REST, CREB and
miRNA in mediating neuronal gene
expression. Genome Biol. 7, R85.
Zeitelhofer, M., Macchi, P., and Dahm,
R. (2008). Perplexing bodies: the
putative roles of P-bodies in neu-
rons. RNA Biol 5, 244–248.
Zheng, D., Zhao, K., and Mehler, M.
F. (2009). ProﬁlingRE1/REST-medi-
ated histone modiﬁcations in the
humangenome.GenomeBiol.10,R9.
Zuccato, C., Belyaev, N., Conforti, P.,
Ooi, L., Tartari, M., Papadimou, E.,
MacDonald, M., Fossale, E., Zeitlin,
S., Buckley, N., and Cattaneo, E.
(2007). Widespread disruption of
repressor element-1 silencing tran-
scription factor/neuron-restrictive
silencer factor occupancy at its tar-
get genes in Huntington’s disease. J.
Neurosci. 27, 6972–6983.
Conﬂict of Interest Statement: The
author declares that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 07December 2010; paper pend-
ing published: 01 January 2011; accepted:
15 February 2011; published online: 28
February 2011.
Citation: Rossbach M (2011) Non-
coding RNAs in neural networks, REST-
assured. Front. Gene. 2:8. doi: 10.3389/
fgene.2011.00008
This article was submitted to Frontiers in
Non-CodingRNA, a specialty of Frontiers
in Genetics.
Copyright © 2011 Rossbach. This is an
open-access article subject to an exclusive
license agreement between the authors
and Frontiers Media SA, which per-
mits unrestricted use, distribution, and
reproduction in any medium, provided
the original authors and source are
credited.
Frontiers in Genetics | Non-Coding RNA February 2011 | Volume 2 | Article 8 | 6
